Hanny Al-Samkari, M.D., of Massachusetts General Hospital in Boston, MA, presented results on systemic bevacizumab for bleeding in hereditary hemorrhagic telangiectasia (HHT) from the InHIBIT-Bleed Study
Thrombin is central to hemostasis, with both pro- and anticoagulant functions. Interest in interactions between complement and coagulation is increasing.
Histones and DNA released from activated immune cells in the form of extracellular traps play an important role in the response to infection by trapping and killing microbial pathogens. However, this may come at a cost.
Charis von Auer-Wegener of the University Medical Center of the Johannes Gutenberg in Mainz, Germany, presented results from research investigating the role of ADAMTS13 activity in predicting recurrence of immune thrombotic thrombocytopenic purpura, or iTTP
Joana Campos of the Institute of Cardiovascular Sciences, College of Medical and Dental Sciences at the University of Birmingham, United Kingdom, presented results from research that looked into the bidirectional interactions between inflammasomes and neutrophil extracellular traps (NETs) in the context of murine deep venous thrombosis (DVT)